Cite
HARVARD Citation
Conway, B. et al. (n.d.). A172 C-EDGE CO-STAR: RISK OF REINFECTION FOLLOWING SUCCESSFUL THERAPY WITH ELBASVIR (EBR) AND GRAZOPREVIR (GZR) IN PERSONS WHO INJECT DRUGS (PWID) RECEIVING OPIOD AGONIST THERAPY (OAT). Journal of the Canadian Association of Gastroenterology. pp. 299-300. [Online].